Sartorius Stedim Ownership

SDMHF Stock  USD 206.00  1.00  0.49%   
Sartorius Stedim Biotech shows a total of 92.17 Million outstanding shares. Sartorius Stedim Biotech has majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 73.81 % of Sartorius Stedim outstanding shares that are owned by insiders indicates they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
  
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sartorius Stedim Biotech. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.

Sartorius Pink Sheet Ownership Analysis

About 74.0% of the company outstanding shares are owned by corporate insiders. The company recorded earning per share (EPS) of 7.94. Sartorius Stedim Biotech last dividend was issued on the 31st of March 2022. The entity had 6:1 split on the 6th of May 2016. Sartorius Stedim Biotech S.A. produces and sells instruments and consumables for the biopharmaceutical industry worldwide. Sartorius Stedim Biotech S.A. is a subsidiary of Sartorius AG. Sartorius Stedim operates under Medical Instruments Supplies classification in the United States and is traded on OTC Exchange. It employs 10409 people.The quote for Sartorius Stedim Biotech is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. To find out more about Sartorius Stedim Biotech contact Joachim Kreuzburg at 33 4 42 84 56 00 or learn more at https://www.sartorius.com.

Currently Active Assets on Macroaxis

Other Information on Investing in Sartorius Pink Sheet

Sartorius Stedim financial ratios help investors to determine whether Sartorius Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Sartorius with respect to the benefits of owning Sartorius Stedim security.